Evaluation of prenatal genetic aberrations in fetuses with gallbladder abnormalities: A retrospective cohort study
- 1Medical Genetic Diagnosis and Therapy Center, Fujian Key Laboratory for Prenatal Diagnosis and Birth Defect, Fujian Provincial Maternity and Children’s Hospital, Affiliated Hospital of Fujian Medical University, Fuzhou, China
Abstract
Background: With the widespread application of chromosomal microarray analysis (CMA) in prenatal diagnosis, fetal gallbladder abnormalities have been found to be associated not only with chromosomal aneuploidies but also with certain syndromes caused by submicroscopic chromosomal structural variants. This study aimed to investigate the molecular etiology of fetal gallbladder abnormalities and to provide additional evidence for clinical screening and genetic counseling regarding these anomalies. Material and methods: This retrospective study included 258 fetuses diagnosed with gallbladder abnormalities through prenatal ultrasonographic screening. Among these, 167 cases underwent both karyotype analysis and CMA, 14 cases received CMA only, and 77 cases underwent karyotype analysis only. The fetuses were categorized into two groups based on the presence of additional structural anomalies: isolated gallbladder abnormalities (Group A), gallbladder abnormalities accompanied by soft markers (Group B) and gallbladder abnormalities accompanied by structural anomalies or other abnormalities (Group C). Within each of the three groups, cases were further subdivided into subgroups A1/B1/C1, A2/B2/C2, A3/B3/C3, and A4/B4/C4, corresponding to fetuses with nonvisualized gallbladder, gallbladder enlargement, small gallbladder, and other gallbladder abnormalities, respectively. Results: Among the total of 258 fetuses, karyotyping identified chromosomal abnormalities in 10 cases (4.2%, 10/240), whereas SNP-array detected abnormalities in 16 cases (8.7%, 16/184). The detection rate of SNP-array was higher than that of traditional chromosome karyotype analysis, and SNP-array identified submicroscopic abnormalities in 7 additional cases that were undetectable by karyotyping. The overall detection rates were significantly higher in gallbladder abnormalities accompanied by structural anomalies or other abnormalities group than that in the isolated gallbladder abnormalities group and gallbladder anomalies accompanied by soft ultrasound markers group(P < 0.05). The highest frequency of chromosomal abnormalities was observed in fetuses presenting with both gallbladder and facial abnormalities. Conclusion: For fetuses with gallbladder abnormalities, prenatal genetic diagnosis is recommended, with chromosomal microarray analysis (CMA) as the preferred testing method. It can improve the detection rate of chromosomal abnormalities associated with fetal gallbladder abnormalities and identify submicroscopic chromosomal structural variants that conventional karyotyping may miss.
Related
- Are Gallbladder Abnormalities in Critically Ill Patients Clinically Relevant? Insights from the Medical Intensive Care Unit of a Medical Center
- Congenital Genitourinary Abnormalities Associated With Prenatal Drug Exposure
- Genetic diagnostic yield of prenatal testing for fetal central nervous system abnormalities: a phenotype-driven study in a large single-center cohort.
- Effect modification of gallbladder wall thickness on the association between fibrosis-4 index and high-risk colorectal adenoma in patients with gallbladder polyps: a retrospective cross-sectional study.
- Prenatal cannabis use disorder and postpartum psychiatric emergency department visits: A retrospective cohort study of trends and associations in California, 2016–2021
BibTeX
@article{xie2026evaluation,
title = {{Evaluation of prenatal genetic aberrations in fetuses with gallbladder abnormalities: A retrospective cohort study}},
author = {Xiaorui Xie and Xiaoqing Wu and Ying Li and Linjuan Su and Meiying Cai and Yuqin Chen and Bin Liang and Na Lin and Liangpu Xu},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0358236},
url = {https://doi.org/10.1371/journal.pone.0358236},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Evaluation of prenatal genetic aberrations in fetuses with gallbladder abnormalities: A retrospective cohort study
AU - Xiaorui Xie
AU - Xiaoqing Wu
AU - Ying Li
AU - Linjuan Su
AU - Meiying Cai
AU - Yuqin Chen
AU - Bin Liang
AU - Na Lin
AU - Liangpu Xu
PY - 2026
DA - 2026/10/15
JO - PLOS One
DO - 10.1371/journal.pone.0358236
UR - https://doi.org/10.1371/journal.pone.0358236
AB - Background: With the widespread application of chromosomal microarray analysis (CMA) in prenatal diagnosis, fetal gallbladder abnormalities have been found to be associated not only with chromosomal aneuploidies but also with certain syndromes caused by submicroscopic chromosomal structural variants. This study aimed to investigate the molecular etiology of fetal gallbladder abnormalities and to provide additional evidence for clinical screening and genetic counseling regarding these anomalies. Material and methods: This retrospective study included 258 fetuses diagnosed with gallbladder abnormalities through prenatal ultrasonographic screening. Among these, 167 cases underwent both karyotype analysis and CMA, 14 cases received CMA only, and 77 cases underwent karyotype analysis only. The fetuses were categorized into two groups based on the presence of additional structural anomalies: isolated gallbladder abnormalities (Group A), gallbladder abnormalities accompanied by soft markers (Group B) and gallbladder abnormalities accompanied by structural anomalies or other abnormalities (Group C). Within each of the three groups, cases were further subdivided into subgroups A1/B1/C1, A2/B2/C2, A3/B3/C3, and A4/B4/C4, corresponding to fetuses with nonvisualized gallbladder, gallbladder enlargement, small gallbladder, and other gallbladder abnormalities, respectively. Results: Among the total of 258 fetuses, karyotyping identified chromosomal abnormalities in 10 cases (4.2%, 10/240), whereas SNP-array detected abnormalities in 16 cases (8.7%, 16/184). The detection rate of SNP-array was higher than that of traditional chromosome karyotype analysis, and SNP-array identified submicroscopic abnormalities in 7 additional cases that were undetectable by karyotyping. The overall detection rates were significantly higher in gallbladder abnormalities accompanied by structural anomalies or other abnormalities group than that in the isolated gallbladder abnormalities group and gallbladder anomalies accompanied by soft ultrasound markers group(P < 0.05). The highest frequency of chromosomal abnormalities was observed in fetuses presenting with both gallbladder and facial abnormalities. Conclusion: For fetuses with gallbladder abnormalities, prenatal genetic diagnosis is recommended, with chromosomal microarray analysis (CMA) as the preferred testing method. It can improve the detection rate of chromosomal abnormalities associated with fetal gallbladder abnormalities and identify submicroscopic chromosomal structural variants that conventional karyotyping may miss.
SN - 1932-6203
ER -